SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AVANIR Pharmaceuticals Announces Filing of IND for AVP-923 for the Treatment of Central Neuropathic Pain in Patients with Multiple Sclerosis